**Key characteristics**
* BCYRN1 is a transmembrane protein that is expressed in the brain and the eye.
* It is a key regulator of the development of the eye, and its absence leads to a number of eye abnormalities, including cataracts, glaucoma, and macular degeneration.
* BCYRN1 is a member of the BCL family of proteins, which are involved in cell survival, proliferation, and differentiation.
* It is expressed in a variety of cell types, including mature astrocytes, microglial cells, nasal mucosa goblet cells, respiratory basal cells, secondary lens fibers, anterior lens cells, lens epithelial cells, eye photoreceptor cells, lens fiber cells, and ciliated columnar cells of the tracheobronchial tree.
**Pathways and functions**
* BCYRN1 is a key regulator of the development of the eye. It is expressed in the developing eye and is required for the formation of the neural tube and the growth of the optic nerve.
* It also plays a role in the maintenance of eye health. It is expressed in the adult eye and is required for the survival of retinal cells, which are responsible for vision.
* BCYRN1 is a potential therapeutic target for a variety of eye diseases. By targeting BCYRN1, it is possible to inhibit the growth of cancer cells and slow the progression of age-related eye diseases.
**Clinical significance**
BCYRN1 is a key gene for the development and maintenance of the eye. Mutations in BCYRN1 have been linked to a number of eye diseases, including cataracts, glaucoma, and macular degeneration. These diseases can lead to significant vision loss and even blindness.
BCYRN1 is a promising target for the treatment of eye diseases. By targeting BCYRN1, it is possible to inhibit the growth of cancer cells and slow the progression of age-related eye diseases.
Disclaimer: This summary is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.
